The Patent Finder
US

Ultrasound Therapy Head with Movement Control

US 7,695,437 Term ended
OverviewFamilyAssignmentsSources & methods

Also listed on Liposonix, Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Collateral for a security interest recorded Jun 13, 2025 (JPMorgan Chase Bank, N.A.).

Term ended Oct 19, 2026 · High confidence

Filed Dec 29, 2004 as application 11/027,912 · Granted Apr 13, 2010
Base term plus 659 days of patent term adjustment (USPTO delay)
Today
20 years from filing
Term ended Oct 19, 2026
2004 2026
Clock starts
Dec 29, 2004
Term ended
Oct 19, 2026
Granted
Apr 13, 2010
base term patent term adjustment after the term ends fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
659
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 659 days past its 20-year base term on prosecution delay. All three maintenance fees were paid, so no fee lapse ended it. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Dec 29, 2004, when this application, 11/027,912, was filedDec 29, 2024High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+659 days, USPTO patent term adjustment recordOct 19, 2026High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderOct 19, 2026High confidence

This family

US 7,695,437this patent
Oct 2026
Oct 2026
US 8,926,533In force
Jan 2027
Jan 2027
Application 12/961,102Abandoned
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Oct 13, 2005
Reel 16639, frame 438
Quistgaard, Jens U.; Etchells, Tim; Darlington, Gregory Paul; Desilets, Charles S.Liposonix, Inc.Assignment of Assignor's Interest
Apr 24, 2009
Reel 22597, frame 363
Liposonix, Inc.Medicis Technologies CorporationChange of Name
Apr 3, 2013
Reel 30147, frame 642
Liposonix, Inc.Silicon Valley BankSecurity Agreement
Apr 18, 2013
Reel 30249, frame 268
Liposonix, Inc.Silicon Valley BankSecurity Interest - Mezzanine Loan
Nov 19, 2013
Reel 31674, frame 454
Liposonix, Inc.Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P.Short-Form Patent Security Agreement
Nov 19, 2013
reel/frame not recorded
Liposonix, Inc.Capital Royalty Partners II L.P.Short-Form Patent Security Agreement
Nov 19, 2013
reel/frame not recorded
Liposonix, Inc.Capital Royalty Partners II - Parallel Fund "a" L.P.Short-Form Patent Security Agreement
Nov 19, 2013
reel/frame not recorded
Liposonix, Inc.Parallel Investment Opportunities Partners II L.P.Short-Form Patent Security Agreement
Jan 24, 2014
Reel 32126, frame 370
Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P.Liposonix, Inc.Release of Security Interest in Patents
Jan 24, 2014
Reel 32126, frame 531
Silicon Valley BankLiposonix, Inc.Release of Security Interest in Patents
Mar 11, 2019
Reel 48556, frame 758
Bausch Health Americas, Inc.; Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.The Bank of New York Mellon, as Notes Collateral AgentSecurity Interest
May 12, 2021
Reel 56228, frame 375
Medicis Technologies CorporationLiposonix, Inc.Change of Name
May 17, 2021
Reel 56257, frame 362
Liposonix, Inc.Solta Medical, Inc.Merger
Jun 13, 2022
Reel 60346, frame 705
Bausch Health Companies Inc.; Bausch Health, Canada Inc.; Bausch Health Ireland Limited; Solta Medical Ireland LimitedThe Bank of New York MellonSecurity Interest
Oct 4, 2022
Reel 61595, frame 66
Bausch Health US, LLC; Bausch Health Americas, Inc.; Medicis Pharmaceutical Corporation; Orapharma, Inc.; Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Solta Medical, Inc.The Bank of New York Mellon, as Notes Collateral AgentSecurity Agreement (First Lien)
Oct 5, 2022
Reel 61606, frame 468
Bausch Health US, LLC; Bausch Health Americas, Inc.; Medicis Pharmaceutical Corporation; Orapharma, Inc.; Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Solta Medical, Inc.The Bank of New York Mellon, as Notes Collateral AgentSecurity Agreement (Second Lien)
Jun 13, 2025
Reel 71564, frame 463
Medicis Pharmaceutical Corporation; Orapharma, Inc.; Bausch Health US, LLC (F/K/A Valeant Pharmaceuticals North America LLC); Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Santarus, Inc.; Bausch Health Americas, Inc.; Solta Medical, Inc.The Bank of New York MellonU.S. Patent Security Agreement
Jun 13, 2025
Reel 71566, frame 200
Medicis Pharmaceutical Corporation; Orapharma, Inc.; Bausch Health US, LLC (F/K/A Valeant Pharmaceuticals North America LLC); Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Santarus, Inc.; Bausch Health Americas, Inc.; Solta Medical, Inc.Jpmorgan Chase Bank, N.a.U.S. Patent Security Agreement
Nov 20, 2025
Reel 73637, frame 126
The Bank of New York Mellon, as Notes Collateral AgentBausch Health Americas, Inc.; Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.Release of Security Interest
Nov 20, 2025
Reel 73654, frame 300
The Bank of New York Mellon, as Notes Collateral AgentBausch Health Companies Inc.; Bausch Health, Canada Inc.; Bausch Health Ireland Limited; Solta Medical Ireland LimitedRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health Americas, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch & Lomb IncorporatedRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health US, LLCRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSolta Medical, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentMedicis Pharmaceutical CorporationRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSalix Pharmaceuticals, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSalix Pharmaceuticals, Ltd.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSantarus, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentOrapharma, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentPrecision Dermatology, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health Companies Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health, Canada Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health Ireland LimitedRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSolta Medical Ireland LimitedRelease of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited